Response Genetics Licenses BRAF Mutation Technology to GlaxoSmithKline

Response Genetics licensed to GSK rights to use its PCR technology as part of the pact.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.